EI
RNAM

EFG International’s Avidity Biosciences RNAM Stock Holding History

EFG International’s Portfolio RNAM Stock Details RNAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-461
Closed -$33.3K – 1100
2025
Q4 		$33.3K Buy
+461
New +$29.8K ﹤0.01% 712

Other funds holding RNAM

CC
Corsicana & Co Corsicana, Texas $158M AUM

EFG International's RNAM Position: Q1 2026 in Review

EFG International sold out of Avidity Biosciences (RNAM) in Q1 2026, closing a stake of 461 shares — an estimated $33.3K sold.

EFG International first reported a position in RNAM in Q4 2025 and held it in 1 quarter. The position peaked at $33.3K in Q4 2025. 1 fund tracked by Wall St. Rank holds RNAM as of Q1 2026.

  • EFG International reported no remaining Avidity Biosciences position as of Q1 2026 after selling out during the quarter.
  • EFG International sold 461 Avidity Biosciences shares in Q1 2026, an estimated $33.3K.
  • EFG International first reported a position in Avidity Biosciences in Q4 2025 and held it in 1 quarter.
  • EFG International's Avidity Biosciences position peaked at $33.3K in Q4 2025.
  • 1 fund tracked by Wall St. Rank held Avidity Biosciences as of Q1 2026.

Based on EFG International's 13F filing for Q1 2026, filed 15 May 2026.